Loading
Latest filing published 14 Mar 2018 for Abattis Bioceuticals Corp., €4,993.
Christina Lynn Boddy appears in our data through filings on Abattis Bioceuticals Corp. shares, published by SEDI. The record holds 6 filings, for trades running from 12 June 2017 to 12 March 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 March 2018: a share grant of €4,993, in Abattis Bioceuticals Corp. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations